Skip to main content
Back
Watch Compare

CV Sciences, Inc.

Data quality: 100%
CVSI
OTC Manufacturing Chemicals
$0.04
▲ $0.00 (1.45%)
Mkt Cap: 5.80 M
Price
$0.03
Mkt Cap
5.80 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue declined -8.93% annually over 5 years
Negative free cash flow of -516,000.0
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.27%
Capital efficient — spends only 0.79% of revenue on capex

Growth

Revenue Growth (5Y)
-8.93%
Below sector avg (1.82%)
Revenue (1Y)-12.20%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-57.33%
Below sector avg (-53.34%)
ROIC-16.67%
Net Margin-6.95%
Op. Margin-3.41%

Safety

Debt / Equity
0.83
Above sector avg (0.31)
Current Ratio1.06
Interest Coverage-0.91

Valuation

PE (TTM)
-6.06
Below sector avg (-1.47)
P/B Ratio3.77
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -6.1 -1.5
P/B 3.8 1.6
ROE % -57.3 -53.3
Net Margin % -7.0 -41.5
Rev Growth 5Y % -8.9 1.8
D/E 0.8 0.3

Analyst Price Target

No analyst coverage available

Earnings Estimates

No forward estimates available

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q32022 N/A -$0.01 —
Q22022 -$0.03 -$0.02 +33.3%
Q12022 -$0.03 -$0.03 0.0%
Q42021 -$0.02 -$0.02 0.0%

All Fundamental Metrics
Growth
Revenue Growth (1Y) -12.20% Revenue Growth (3Y) -7.18%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -8.93% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 13.79 M Net Income (TTM) -958,000.0
ROE -57.33% ROA -12.82%
Gross Margin 48.97% Operating Margin -3.41%
Net Margin -6.95% Free Cash Flow (TTM) -516,000.0
ROIC -16.67% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.83 Current Ratio 1.06
Interest Coverage -0.91 Asset Turnover 1.85
Working Capital 311,000 Tangible Book Value 447,000
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6.06 Forward P/E N/A
P/B Ratio 3.77 P/S Ratio 0.42
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8.89%
Market Cap 5.80 M Enterprise Value 7.08 M
Per Share
EPS (Diluted TTM) -0.01 Revenue / Share 0.07
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.79% FCF Conversion 53.86%
SBC-Adj. FCF -977,000 Growth Momentum -3.27

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 13.79 M 15.71 M 16.00 M 16.21 M 20.05 M
Net Income -958,000.0 -2.39 M 3.10 M -8.21 M -15.55 M
EPS (Diluted) -0.01 -0.01 0.02 -0.07 -0.14
Gross Profit 6.75 M 7.17 M 7.09 M 5.55 M 8.62 M
Operating Income -470,000.0 -2.19 M 3.36 M -6.85 M -18.45 M
EBITDA — — — — —
R&D Expenses 122,000.0 118,000.0 151,000.0 307,000.0 1.19 M
SG&A Expenses 7.62 M 9.24 M 9.75 M — 25.88 M
D&A 192,000.0 334,000.0 235,000.0 992,000.0 1.15 M
Interest Expense 517,000.0 — 600,000.0 600,000.0 -140,000.0
Income Tax 9,000.0 -8,000.0 -6,000.0 -47,000.0 -87,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 6.96 M 7.93 M 9.20 M 12.74 M 18.07 M
Total Liabilities 5.49 M 6.13 M 6.30 M 13.51 M 14.52 M
Shareholders' Equity 1.47 M 1.80 M 2.90 M -777,000.0 3.54 M
Total Debt 1.65 M — — — 0.0
Cash & Equivalents — — — 611,000.0 1.38 M
Current Assets 5.13 M 6.24 M 7.94 M 11.13 M 14.19 M
Current Liabilities 5.00 M 6.11 M 6.12 M 13.31 M 14.46 M